EUVIMEDEUVIMED entdecken
Systematische Übersicht

Emphasizing outcomes: Systematic Review of EUS-Guided Radiofrequency Ablation Compared with Surgery for Pancreatic Insulinoma

T Haziri, S Driton, M Kushtrim

Endoscopy · 01.06.2026 · 58 (S 03 S 03) · S568

DOI: 10.1055/s-0046-1821704 ↗

Kurz gefasst

Systematische Übersicht in der Zeitschrift Endoscopy, erschienen am 01.06.2026. Verfasst von T Haziri und 2 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aims

Objective Minimally invasive techniques, including endoscopic ultrasound-guided radiofrequency ablation (EUS-RFA), have been proposed as potential alternatives to surgery for the treatment of pancreatic insulinomas (IP). The aim of this systematic review was to synthesize existing evidence on the safety, efficacy, and long-term outcomes of EUS-RFA compared with traditional surgical approaches [ 1 ].

Methods

Methods A systematic search was conducted in PubMed, Scopus, and Embase databases up to 2024. Inclusion was limited to studies reporting on the treatment of IP with either EUS-RFA or surgery that provided data on complications, clinical response, recurrence, and long-term follow-up. Strict selection criteria were applied, and the PRISMA guidelines were followed for the review process. Data on follow-up duration (up to 24–36 months) and monitoring strategies (clinical and radiological) were analyzed as secondary outcomes.

Results

Results Out of 742 identified articles, 22 studies met the inclusion criteria. Evidence indicated that EUS-RFA had a superior safety profile compared with surgery, with a low rate of adverse events. Effectiveness in normalizing glucose levels and controlling hypoglycemic symptoms was similar between the approaches. Long-term follow-up (24–36 months) in most studies showed stability of clinical response, with sporadic recurrences typically managed with repeat EUS-RFA procedures. However, methodological heterogeneity and the limited number of comparative studies remain significant limitations.

Conclusions

Conclusion Current evidence suggests that EUS-RFA represents a safe and effective alternative to surgery for patients with pancreatic insulinoma, offering clear advantages in terms of invasiveness and recovery time. Long-term outcome data are promising, but the evidence remains fragmented. Prospective, comparative, and standardized studies are required to definitively establish the role of EUS-RFA as a first-line therapy. Publication History Article published online: 05 June 2026 © 2026. European Society of Gastrointestinal Endoscopy. All rights reserved. Georg Thieme Verlag KG Oswald-Hesse-Straße 50, 70469 Stuttgart, Germany

Zitieren

APA

Haziri, T., Driton, S., & Kushtrim, M. (2026). Emphasizing outcomes: Systematic Review of EUS-Guided Radiofrequency Ablation Compared with Surgery for Pancreatic Insulinoma. Endoscopy, 58(S 03 S 03), S568. https://doi.org/10.1055/s-0046-1821704

Vancouver

Haziri T, Driton S, Kushtrim M. Emphasizing outcomes: Systematic Review of EUS-Guided Radiofrequency Ablation Compared with Surgery for Pancreatic Insulinoma. Endoscopy. 2026;58(S 03 S 03):S568. doi:10.1055/s-0046-1821704

BibTeX
@article{Haziri2026,
  author = {Haziri, T and Driton, S and Kushtrim, M},
  title = {Emphasizing outcomes: Systematic Review of EUS-Guided Radiofrequency Ablation Compared with Surgery for Pancreatic Insulinoma},
  journal = {Endoscopy},
  year = {2026},
  volume = {58},
  number = {S 03 S 03},
  pages = {S568},
  doi = {10.1055/s-0046-1821704}
}
Kostenlos starten →